Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bruttomesso

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 8, 2011
Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trialJ Hermanides, K Nørgaard, D Bruttomesso, et al.
Diabetes, Obesity & Metabolism|August 19, 2014
Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditionsJ Kropff, D Bruttomesso, W Doll, et al.
Diabetes & Metabolism|April 9, 2011
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)D Bruttomesso, M Bonomo, S Costa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2009
Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injectionM Franciosi, A Maione, B Pomili, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2016
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trialJ Kropff, J DeJong, S Del Favero, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 2008
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargineD Bruttomesso, D Crazzolara, A Maran, et al.
Journal of Endocrinological Investigation|March 9, 2019
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesE Cipponeri, N Vitturi, V Mariano, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of lifeD Bruttomesso, A Pianta, D Crazzolara, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2001
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trialG Annuzzi, S Del Prato, R Arcari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2006
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trialR P L M Hoogma, P J Hammond, R Gomis, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Diabetic Medicine : a Journal of the British Diabetic Association|February 8, 2011
Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trialJ Hermanides, K Nørgaard, D Bruttomesso, et al.
Diabetes, Obesity & Metabolism|August 19, 2014
Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditionsJ Kropff, D Bruttomesso, W Doll, et al.
Diabetes & Metabolism|April 9, 2011
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)D Bruttomesso, M Bonomo, S Costa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 15, 2009
Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injectionM Franciosi, A Maione, B Pomili, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2016
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trialJ Kropff, J DeJong, S Del Favero, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 2008
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargineD Bruttomesso, D Crazzolara, A Maran, et al.
Journal of Endocrinological Investigation|March 9, 2019
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesE Cipponeri, N Vitturi, V Mariano, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2002
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of lifeD Bruttomesso, A Pianta, D Crazzolara, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 10, 2001
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trialG Annuzzi, S Del Prato, R Arcari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2006
Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trialR P L M Hoogma, P J Hammond, R Gomis, et al.
Pageof 6